THE NEW BUSINESS MODEL FOR EXPANDED HEMATOLOGY PARAMETERS – IMMATURE GRANULOCYTE (IG)
THE NEW BUSINESS MODEL FOR EXPANDED HEMATOLOGY PARAMETERS – IMMATURE GRANULOCYTE (IG)

These are transformative times in the healthcare industry and especially for the clinical laboratory. Significant reimbursement
cuts and payment reform linked to quality measures are driving a new approach to laboratory testing. Laboratorians faced with a
changing business model and growing staff shortages are increasingly being asked to justify the value the laboratory provides.

LEARN MORE